Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100,358 | 85 | 62.5% |
| Consulting Fee | $37,895 | 22 | 23.6% |
| Travel and Lodging | $11,262 | 51 | 7.0% |
| Food and Beverage | $10,884 | 318 | 6.8% |
| Education | $293.95 | 10 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $134,486 | 228 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $13,229 | 46 | $0 (2024) |
| Endo USA, Inc. | $8,723 | 12 | $0 (2024) |
| COLOPLAST CORP | $895.92 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $515.13 | 30 | $0 (2024) |
| ABBVIE INC. | $329.77 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $217.21 | 11 | $0 (2024) |
| Antares Pharma, Inc. | $195.56 | 8 | $0 (2024) |
| PFIZER INC. | $191.48 | 10 | $0 (2024) |
| 180 Medical, Inc. | $147.10 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79,382 | 147 | Boston Scientific Corporation ($69,528) |
| 2023 | $37,388 | 111 | Boston Scientific Corporation ($29,885) |
| 2022 | $25,795 | 80 | BOSTON SCIENTIFIC CORPORATION ($19,287) |
| 2021 | $8,565 | 42 | BOSTON SCIENTIFIC CORPORATION ($7,634) |
| 2020 | $7,388 | 27 | Boston Scientific Corporation ($7,134) |
| 2019 | $1,573 | 60 | Boston Scientific Corporation ($598.39) |
| 2018 | $601.97 | 19 | BOSTON SCIENTIFIC CORPORATION ($420.30) |
All Payment Transactions
486 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Travel and Lodging | Cash or cash equivalent | $213.21 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Food and Beverage | Cash or cash equivalent | $59.82 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Travel and Lodging | Cash or cash equivalent | $12.00 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Boston Scientific Corporation | AMS 700 CXR RTE Kit (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: AMS 700 CXR RTE Kit_URO | ||||||
| 12/12/2024 | Boston Scientific Corporation | AMS 700 CXR RTE Kit (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: AMS 700 CXR RTE Kit_URO | ||||||
| 12/12/2024 | Boston Scientific Corporation | AMS 700 CXR RTE Kit (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: AMS 700 CXR RTE Kit_URO | ||||||
| 12/12/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: AMS 700_URO | ||||||
| 12/11/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Travel and Lodging | Cash or cash equivalent | $267.14 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Travel and Lodging | Cash or cash equivalent | $241.21 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $225.00 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/03/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Travel and Lodging | In-kind items and services | $661.58 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Travel and Lodging | In-kind items and services | $328.04 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $111.23 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $394.51 | General |
| Category: General - Therapies_URO | ||||||
| 11/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $90.12 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 11/14/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 11/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,042 | 1,573 | $243,880 | $87,194 |
| 2022 | 23 | 1,489 | 2,925 | $410,942 | $129,891 |
| 2021 | 26 | 1,528 | 2,873 | $356,989 | $126,115 |
| 2020 | 24 | 1,042 | 1,248 | $315,469 | $108,972 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 234 | $61,612 | $21,712 | 35.2% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 28 | 377 | $26,458 | $12,964 | 49.0% |
| 54405 | Insertion of multicomponent inflatable penile implant | Facility | 2023 | 21 | 21 | $30,335 | $12,652 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 104 | $19,415 | $6,284 | 32.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $17,097 | $5,634 | 33.0% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 28 | 116 | $8,141 | $3,989 | 49.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 29 | $10,740 | $3,625 | 33.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 12 | 12 | $7,817 | $2,199 | 28.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 26 | 29 | $18,892 | $1,629 | 8.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,622 | $1,337 | 36.9% |
| 87556 | Detection test by nucleic acid for mycobacteria tuberculosis (tb bacteria), amplified probe technique | Office | 2023 | 28 | 29 | $2,417 | $1,185 | 49.0% |
| 51705 | Simple change of bladder tube | Office | 2023 | 11 | 18 | $3,667 | $1,043 | 28.4% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 28 | 29 | $2,035 | $997.31 | 49.0% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 28 | 29 | $2,035 | $997.31 | 49.0% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 27 | 28 | $1,965 | $962.92 | 49.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 18 | 26 | $3,383 | $950.12 | 28.1% |
| 11980 | Placement of hormone pellet under skin | Office | 2023 | 11 | 13 | $2,559 | $759.65 | 29.7% |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | Office | 2023 | 22 | 22 | $1,544 | $756.58 | 49.0% |
| 87496 | Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique | Office | 2023 | 22 | 22 | $1,544 | $756.58 | 49.0% |
| 87532 | Detection test by nucleic acid for herpes virus-6, amplified probe technique | Office | 2023 | 22 | 22 | $1,544 | $756.58 | 49.0% |
| 87563 | Detection of mycoplasma genitalium by dna or rna probe | Office | 2023 | 22 | 22 | $1,544 | $756.58 | 49.0% |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | Office | 2023 | 22 | 22 | $1,544 | $756.58 | 49.0% |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | Office | 2023 | 22 | 22 | $1,544 | $756.58 | 49.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 85 | 89 | $2,670 | $717.66 | 26.9% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 17 | 18 | $1,263 | $619.02 | 49.0% |
About Dr. James Mcbride, MD
Dr. James Mcbride, MD is a Urology healthcare provider based in Durango, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2012. The National Provider Identifier (NPI) number assigned to this provider is 1891057923.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Mcbride, MD has received a total of $160,693 in payments from pharmaceutical and medical device companies, with $79,382 received in 2024. These payments were reported across 486 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($100,358).
As a Medicare-enrolled provider, Mcbride has provided services to 5,101 Medicare beneficiaries, totaling 8,619 services with total Medicare billing of $452,171. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Durango, CO
- Active Since 06/14/2012
- Last Updated 12/15/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891057923
Products in Payments
- AMS 700 CXR RTE Kit (Device) $36,934
- XIAFLEX (Biological) $21,776
- TACTRA (Device) $14,290
- General - Erectile Dysfunction (Device) $9,721
- AMS (Device) $5,221
- AMS 700 (Device) $5,182
- GENERAL THERAPIES (Device) $5,038
- GENERAL - THERAPIES (Device) $1,793
- AMS 800 Artificial Urinary Sphincter (Device) $1,404
- ADVANCE (Device) $1,313
- AMS 700 CXR RTE KIT (Device) $1,241
- GENERAL - BPH (Device) $750.00
- Titan (Device) $614.51
- XTANDI (Drug) $462.57
- BOTOX (Biological) $292.77
- TITAN (Device) $203.96
- ERLEADA (Drug) $197.31
- Xtandi (Drug) $157.74
- PROVENGE (Drug) $133.33
- GENERAL ERECTILE DYSFUNCTION (Device) $128.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.